In the case of OSCC, it is plausible that the immunosuppressive effects of NETs, such as recruitment of MDSCs, increased expression of PD-L1, and inhibition of cytotoxic T cell activity, outweigh any potential anti-tumor mechanisms. The gene discussed is CD274; the disease is neoplasm.